<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="154724">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01917591</url>
  </required_header>
  <id_info>
    <org_study_id>KS-0070</org_study_id>
    <nct_id>NCT01917591</nct_id>
  </id_info>
  <brief_title>Healing of Punch Graft Wounds. Comparative Study Between MariGen and Oasis: a Non-inferiority Study</brief_title>
  <official_title>Healing of Punch Graft Wounds With Two Biologic Exracellular Matrices; a Non-inferiority Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kerecis Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kerecis Ltd.</source>
  <oversight_info>
    <authority>Iceland: Ministry of Health and Social Security</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective is to determine, if healing of punch biopsy wounds treated with the fish skin
      derived MariGen Wound dressing is non-inferior to healing with wounds treated with pig
      intestines derived Oasis Sheet wound dressing. Secondary endpoints are: Incidence of
      erythema, Pain, Infection, Quantitative measurements of autoantibodies at baseline and 4
      weeks after start of treatment
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Actual">July 2013</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>wound healing</measure>
    <time_frame>28 days</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Autoimmune investigations</measure>
    <time_frame>28 days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Measurement of auto-antibodies including anti-collagen I and II antibodies</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of erythema</measure>
    <time_frame>28 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>28 days</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infection</measure>
    <time_frame>28 days</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">81</enrollment>
  <condition>Punch Biopsy Wounds</condition>
  <condition>Healing Times</condition>
  <arm_group>
    <arm_group_label>MariGen Wound</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Fish derived extra cellular matrix</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oasis Sheet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pig intestine derived extra cellular matrix</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Punch biopsies treated with MariGen Wound ECM dressing</intervention_name>
    <description>Weekly dressing changes and review of wounds.</description>
    <arm_group_label>MariGen Wound</arm_group_label>
    <other_name>MariGen Wound ECM wound dressings.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Punch biopsies treated with Oasis ECM dressing</intervention_name>
    <description>Weekly dressing changes and wound review</description>
    <arm_group_label>Oasis Sheet</arm_group_label>
    <other_name>Oasis ECM wound dressing</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt;18 yrs

          -  Healthy individual

          -  Signature of informed consent

        Exclusion Criteria:

          -  Autoimmune disease

          -  Immunosuppressive treatment

          -  Use of addictive drugs

          -  Excessive use of alcohol

          -  Known fish allergy

          -  Known allergy to proteins with porcine origin

          -  Peripheral vascular disease

          -  Pregnant women

          -  Persons receiving anticoagulation therapy or systemic corticosteroids will be
             excluded.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hugrun Thorsteinsdottir, MD Derm</last_name>
    <role>Principal Investigator</role>
    <affiliation>The National University Hospital of Iceland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>LÃ¦knastofur Skipholti</name>
      <address>
        <city>Reykjavik</city>
        <zip>105</zip>
        <country>Iceland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iceland</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>August 5, 2013</lastchanged_date>
  <firstreceived_date>July 29, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Bandages</keyword>
  <keyword>Biological Dressings</keyword>
  <keyword>Chronic Disease</keyword>
  <keyword>Collagen</keyword>
  <keyword>Epithelium</keyword>
  <keyword>Extracellular Matrix</keyword>
  <keyword>Extra Cellular Matrix</keyword>
  <keyword>Fibroblasts</keyword>
  <keyword>Granulation Tissue</keyword>
  <keyword>Leg Ulcer</keyword>
  <keyword>Middle Aged</keyword>
  <keyword>Prospective Studies</keyword>
  <keyword>Soft Tissue Injuries</keyword>
  <keyword>Treatment Outcome</keyword>
  <keyword>Varicose Ulcer</keyword>
  <keyword>Wound Healing</keyword>
  <keyword>Wounds and Injuries</keyword>
  <keyword>biopsy</keyword>
  <keyword>autoimmunity</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
